| Charles Stebner Mosteller, MD | |
|
3701 Dauphin St, Mobile, AL 36608-1756 | |
| (251) 341-3368 | |
| (251) 341-3371 |
| Full Name | Charles Stebner Mosteller |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 3701 Dauphin St, Mobile, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235121492 | NPI | - | NPPES |
| 0810135 | Other | AL | UNITED HEALTHCARE PROV # |
| 51034523 | Other | AL | BLUE CROSS PROVIDER # |
| 4204103 | Other | AL | AETNA PIN |
| E56728 | Other | AL | HEALTHSPRING PROVIDER # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 00014530 (Alabama) | Primary |
| Entity Name | Premier Health Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538154760 PECOS PAC ID: 6608869342 Enrollment ID: O20040407000654 |
News Archive
No matter what novel objects we come to behold, our brains effortlessly take us from an initial "What's that?" to "Oh, that old thing" after a few casual encounters. In research that helps shed light on the malleability of this recognition process, Brown University neuroscientists have teased apart the potentially different roles that two distinct cell types may play.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
Salix Pharmaceuticals, Ltd. today announced that based on a telephone conversation with the U.S. Food and Drug Administration held last evening, the Company anticipates receiving a Complete Response Letter on or before the March 7, 2011 PDUFA goal date for the supplemental New Drug Application for XIFAXAN 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome and IBS-related bloating.
What:Scientists from the National Institutes of Health have discovered how catheter-related bacterial infection develops and disseminates to become a potentially life-threatening condition. The study, which included research on Staphylococcus epidermidis in mice implanted with catheters, could have important implications for understanding many types of bacterial biofilm infections, including those caused by methicillin-resistant S. aureus (MRSA).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Stebner Mosteller, MD 2880 Dauphin St, Mobile, AL 36606-2457 Ph: (251) 341-3368 | Charles Stebner Mosteller, MD 3701 Dauphin St, Mobile, AL 36608-1756 Ph: (251) 341-3368 |
News Archive
No matter what novel objects we come to behold, our brains effortlessly take us from an initial "What's that?" to "Oh, that old thing" after a few casual encounters. In research that helps shed light on the malleability of this recognition process, Brown University neuroscientists have teased apart the potentially different roles that two distinct cell types may play.
In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.
Salix Pharmaceuticals, Ltd. today announced that based on a telephone conversation with the U.S. Food and Drug Administration held last evening, the Company anticipates receiving a Complete Response Letter on or before the March 7, 2011 PDUFA goal date for the supplemental New Drug Application for XIFAXAN 550 mg tablets for the proposed indication of treatment of non-constipation irritable bowel syndrome and IBS-related bloating.
What:Scientists from the National Institutes of Health have discovered how catheter-related bacterial infection develops and disseminates to become a potentially life-threatening condition. The study, which included research on Staphylococcus epidermidis in mice implanted with catheters, could have important implications for understanding many types of bacterial biofilm infections, including those caused by methicillin-resistant S. aureus (MRSA).
› Verified 7 days ago
Jeffrey St. John, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 601 Providence Park Dr E, Mobile, AL 36695 Phone: 251-650-2020 Fax: 251-650-1010 | |
Rollins Lynne Tindell Jr., M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Richard Joseph Duffey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Valerie Lanette Vick, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2880 Dauphin St, Mobile, AL 36606 Phone: 251-473-1900 Fax: 251-470-8943 | |
Mark Scott Brown, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6576 Airport Blvd Ste B200, Mobile, AL 36608 Phone: 251-650-5437 Fax: 800-689-2131 | |
Matthew Wooley Mosteller, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3701 Dauphin St, Mobile, AL 36608 Phone: 251-341-3368 Fax: 251-341-3371 | |
Andrew Pope Terry, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3701 Dauphin St, Mobile, AL 36608 Phone: 251-341-3368 Fax: 251-341-3371 |